miR-338 inhibits the metastasis of lung cancer by targeting integrin β3

Area of Science:

• Molecular Biology
• Oncology
• Genetics

Background:

• MicroRNA-338 (miR-338), an intronic miRNA from apoptosis-associated tyrosine kinase (AATK), is implicated in tumor proliferation and apoptosis.
• Its specific role and regulatory mechanisms in lung cancer remain largely unknown.

Purpose of the Study:

• To investigate the function and regulatory mechanism of miR-338 in lung cancer.
• To determine the association of miR-338 expression with clinical features and patient outcomes.

Main Methods:

• Analysis of miR-338 expression in lung cancer tissues and cell lines.
• In vitro functional assays (adhesion, migration, invasion) and in vivo tumor formation studies in nude mice.
• Identification of miR-338 target genes using molecular biology techniques.

Main Results:

• miR-338 was significantly downregulated in 115 lung cancer tissues and 5 cell lines.
• Low miR-338 levels correlated with tumor emboli, advanced TNM stage, recurrence, and poor survival.
• Restoring miR-338 impaired lung cancer cell adhesion, migration, invasion, and in vivo tumor formation.
• Integrin β3 (ITGB3) was identified as a novel direct target of miR-338.

Conclusions:

• miR-338 acts as a tumor suppressor in lung cancer, inhibiting metastasis.
• The miR-338/ITGB3 axis represents a new regulatory mechanism in lung cancer progression.
• miR-338 may serve as a potential therapeutic target for lung cancer treatment.